Lupus News

Patients with systemic lupus erythematosus, especially those who are positive for anti-Sm antibodies, are at greater risk for adverse events associated with trimethoprim-sulfamethoxazole, according to data presented at the ACR Convergence 2020 virtual meeting.

Corrected QT interval was unaffected by hydroxychloroquine use in patients with systemic lupus erythematosus — both with and without chronic kidney disease, according to data presented at the ACR Convergence 2020 virtual meeting.

The height of the COVID-19 pandemic in New York caused “substantial” medication changes for rheumatology patients in order to minimize infection risk and potential harm, according to findings published in Arthritis Care & Research.

A complex autoimmune disease like lupus requires multi-pronged, multifactorial approaches for both individual patient management and for broader research and advocacy initiatives. It is difficult to diagnose, treat, and study in clinical trials.

Hydroxychloroquine fails to prevent COVID-19 among adults with rheumatoid arthritis, systemic lupus erythematosus or other related diseases, according to data published in The Lancet Rheumatology.

A multidisciplinary post-discharge intervention aimed at reducing 30-day hospital readmission rates among patients with systemic lupus erythematosus is feasible, but more data is needed to determine if it is effective, according to researchers.

Rheumatologists treating patients with systemic lupus erythematosus should focus more on hydroxychloroquine blood levels than on prescribed dosage based on weight, according to a speaker at the 2020 Congress of Clinical Rheumatology-West.

Grouping patients with systemic lupus erythematosus into subsets based on inflammatory and noninflammatory symptoms may help them better understand their disease and treatment, according to a speaker at the 2020 Congress of Clinical Rheumatology-West.

Understanding the interplay between environmental, genetic and other factors is critical to lupus management, according to a presenter at the 2020 Congress of Clinical Rheumatology-West.

Cancers — particularly lung cancer — were more likely to occur among patients with systemic lupus erythematosus who smoked, whereas use of antimalarials was linked to lower cancer risk, researchers noted.